LifeMD Book Value per Share vs Enterprise Value Analysis

LFMD Stock

USD 9.61 0.05 0.52%

LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Book Value Per Share and its Enterprise Value accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Book Value Per Share vs Enterprise Value

Book Value per Share vs Enterprise Value Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Book Value per Share account and Enterprise Value. At this time, the significance of the direction appears to have almost no relationship.

The correlation between LifeMD's Book Value per Share and Enterprise Value is 0.1. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Enterprise Value in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Book Value per Share and Enterprise Value is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of LifeMD Inc are associated (or correlated) with its Enterprise Value. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Enterprise Value has no effect on the direction of Book Value per Share i.e., LifeMD's Book Value per Share and Enterprise Value go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Enterprise Value

Enterprise Value (or EV) is usually referred to as LifeMD theoretical takeover price. In the event of an acquisition, an acquirer would have to take on LifeMD Inc debt, but would also pocket its cash. Enterprise Value is more accurate representation of LifeMD value than its market capitalization because it takes into account all of LifeMD Inc existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.32.

	2021	2022	2023	2024 (projected)
Interest Expense	3.0M	1.3M	2.6M	2.7M
Depreciation And Amortization	4.9M	7.5M	6.6M	6.9M

Interest Expense Depreciation And Amortization

LifeMD fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Other Current Assets	Net Tangible Assets
Total Assets		0.86	0.95	0.94	0.48	0.76	-0.76	-0.94	0.88	0.96	0.88	0.96	0.89	0.03	0.95	0.84	0.81	0.97	0.95	0.76	0.99	0.39	0.07	0.89	0.95	-0.34
Short Long Term Debt Total	0.86		0.82	0.84	0.07	0.4	-0.37	-0.82	0.72	0.74	0.89	0.74	0.97	0.13	0.83	1.0	0.72	0.84	0.93	0.4	0.8	0.26	0.18	0.95	0.93	-0.66
Other Current Liab	0.95	0.82		0.97	0.34	0.83	-0.65	-0.97	0.88	0.85	0.94	0.85	0.89	0.11	0.99	0.77	0.91	0.98	0.96	0.83	0.9	0.61	0.14	0.91	0.95	-0.45
Total Current Liabilities	0.94	0.84	0.97		0.24	0.79	-0.59	-1.0	0.95	0.81	0.96	0.81	0.92	0.0	0.99	0.79	0.94	1.0	0.98	0.79	0.88	0.65	0.04	0.94	0.92	-0.55
Total Stockholder Equity	0.48	0.07	0.34	0.24		0.54	-0.92	-0.25	0.29	0.7	0.04	0.7	0.04	-0.08	0.3	0.08	0.07	0.32	0.2	0.54	0.61	-0.19	-0.07	0.03	0.28	0.66
Property Plant And Equipment Net	0.76	0.4	0.83	0.79	0.54		-0.74	-0.81	0.74	0.72	0.68	0.72	0.54	-0.17	0.81	0.34	0.75	0.81	0.68	1.0	0.74	0.68	-0.15	0.58	0.65	-0.09
Net Debt	-0.76	-0.37	-0.65	-0.59	-0.92	-0.74		0.6	-0.63	-0.9	-0.39	-0.9	-0.38	0.1	-0.62	-0.37	-0.41	-0.65	-0.54	-0.74	-0.85	-0.08	0.08	-0.38	-0.58	-0.34
Retained Earnings	-0.94	-0.82	-0.97	-1.0	-0.25	-0.81	0.6		-0.94	-0.81	-0.96	-0.81	-0.91	0.02	-0.99	-0.77	-0.94	-1.0	-0.97	-0.81	-0.88	-0.66	-0.02	-0.93	-0.91	0.54
Accounts Payable	0.88	0.72	0.88	0.95	0.29	0.74	-0.63	-0.94		0.79	0.83	0.79	0.8	-0.05	0.92	0.67	0.89	0.93	0.9	0.74	0.84	0.62	-0.02	0.82	0.82	-0.44
Cash	0.96	0.74	0.85	0.81	0.7	0.72	-0.9	-0.81	0.79		0.7	1.0	0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.18	0.03	0.72	0.86	-0.06
Non Current Assets Total	0.88	0.89	0.94	0.96	0.04	0.68	-0.39	-0.96	0.83	0.7		0.7	0.96	0.07	0.95	0.85	0.93	0.95	0.97	0.68	0.78	0.65	0.11	0.98	0.92	-0.71
Cash And Short Term Investments	0.96	0.74	0.85	0.81	0.7	0.72	-0.9	-0.81	0.79	1.0	0.7		0.73	-0.01	0.84	0.73	0.63	0.86	0.83	0.72	0.99	0.18	0.03	0.72	0.86	-0.06
Net Receivables	0.89	0.97	0.89	0.92	0.04	0.54	-0.38	-0.91	0.8	0.73	0.96	0.73		0.1	0.91	0.95	0.84	0.91	0.97	0.54	0.81	0.45	0.14	0.99	0.93	-0.71
Common Stock Total Equity	0.03	0.13	0.11	0.0	-0.08	-0.17	0.1	0.02	-0.05	-0.01	0.07	-0.01	0.1		0.05	0.15	0.18	-0.01	0.05	-0.17	0.02	0.01	1.0	0.07	0.19	-0.09
Common Stock Shares Outstanding	0.95	0.83	0.99	0.99	0.3	0.81	-0.62	-0.99	0.92	0.84	0.95	0.84	0.91	0.05		0.78	0.94	0.99	0.97	0.81	0.9	0.63	0.09	0.93	0.93	-0.5
Non Current Liabilities Total	0.84	1.0	0.77	0.79	0.08	0.34	-0.37	-0.77	0.67	0.73	0.85	0.73	0.95	0.15	0.78		0.66	0.79	0.9	0.34	0.79	0.17	0.2	0.92	0.91	-0.62
Inventory	0.81	0.72	0.91	0.94	0.07	0.75	-0.41	-0.94	0.89	0.63	0.93	0.63	0.84	0.18	0.94	0.66		0.92	0.89	0.75	0.72	0.81	0.2	0.87	0.83	-0.63
Other Stockholder Equity	0.97	0.84	0.98	1.0	0.32	0.81	-0.65	-1.0	0.93	0.86	0.95	0.86	0.91	-0.01	0.99	0.79	0.92		0.98	0.81	0.92	0.6	0.02	0.93	0.93	-0.49
Total Liab	0.95	0.93	0.96	0.98	0.2	0.68	-0.54	-0.97	0.9	0.83	0.97	0.83	0.97	0.05	0.97	0.9	0.89	0.98		0.68	0.89	0.52	0.09	0.98	0.96	-0.6
Property Plant And Equipment Gross	0.76	0.4	0.83	0.79	0.54	1.0	-0.74	-0.81	0.74	0.72	0.68	0.72	0.54	-0.17	0.81	0.34	0.75	0.81	0.68		0.74	0.68	-0.15	0.58	0.65	-0.09
Total Current Assets	0.99	0.8	0.9	0.88	0.61	0.74	-0.85	-0.88	0.84	0.99	0.78	0.99	0.81	0.02	0.9	0.79	0.72	0.92	0.89	0.74		0.27	0.06	0.8	0.91	-0.18
Short Term Debt	0.39	0.26	0.61	0.65	-0.19	0.68	-0.08	-0.66	0.62	0.18	0.65	0.18	0.45	0.01	0.63	0.17	0.81	0.6	0.52	0.68	0.27		0.02	0.53	0.42	-0.55
Common Stock	0.07	0.18	0.14	0.04	-0.07	-0.15	0.08	-0.02	-0.02	0.03	0.11	0.03	0.14	1.0	0.09	0.2	0.2	0.02	0.09	-0.15	0.06	0.02		0.11	0.23	-0.12
Current Deferred Revenue	0.89	0.95	0.91	0.94	0.03	0.58	-0.38	-0.93	0.82	0.72	0.98	0.72	0.99	0.07	0.93	0.92	0.87	0.93	0.98	0.58	0.8	0.53	0.11		0.94	-0.73
Other Current Assets	0.95	0.93	0.95	0.92	0.28	0.65	-0.58	-0.91	0.82	0.86	0.92	0.86	0.93	0.19	0.93	0.91	0.83	0.93	0.96	0.65	0.91	0.42	0.23	0.94		-0.51
Net Tangible Assets	-0.34	-0.66	-0.45	-0.55	0.66	-0.09	-0.34	0.54	-0.44	-0.06	-0.71	-0.06	-0.71	-0.09	-0.5	-0.62	-0.63	-0.49	-0.6	-0.09	-0.18	-0.55	-0.12	-0.73	-0.51

Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Short Long Term Debt Total	844.7K	1.1M	1.8M	4.1M	18.9M	19.9M
Other Current Liab	3.1M	1.4M	11.6M	12.2M	13.9M	14.6M
Total Current Liabilities	4.0M	13.5M	22.8M	31.4M	34.8M	36.5M
Total Stockholder Equity	(988.2K)	1.4M	26.9M	(6.8M)	3.5M	2.1M
Net Debt	(261.9K)	(8.1M)	(39.5M)	168.5K	(14.2M)	(13.5M)
Retained Earnings	(16.6M)	(80.2M)	(141.9M)	(190.6M)	(214.3M)	(203.6M)
Accounts Payable	3.1M	10.4M	9.1M	10.1M	11.1M	11.6M
Cash	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Non Current Assets Total	699.1K	990.3K	5.0M	14.4M	15.9M	16.7M
Cash And Short Term Investments	1.1M	9.2M	41.3M	4.0M	33.1M	34.8M
Net Receivables	97.4K	648.4K	980.1K	2.8M	5.3M	5.5M
Common Stock Total Equity	534.0K	234.3K	307.0K	315.5K	362.9K	377.1K
Common Stock Shares Outstanding	9.9M	14.3M	27.0M	31.0M	33.9M	35.6M
Liabilities And Stockholders Equity	3.4M	13.1M	49.9M	25.7M	58.5M	61.4M
Non Current Liabilities Total	600.0K	385.3K	1.3M	1.6M	18.1M	19.0M
Inventory	950.1K	1.3M	1.6M	3.7M	2.8M	2.9M
Other Stockholder Equity	15.1M	77.6M	164.4M	178.9M	217.4M	228.3M
Total Liab	4.6M	13.9M	24.1M	33.0M	52.9M	55.6M
Total Current Assets	2.7M	12.1M	44.9M	11.3M	42.6M	44.7M
Short Term Debt	814.7K	779.1K	670.9K	3.6M	930.8K	715.0K
Common Stock	534.0K	234.3K	307.0K	315.5K	383.6K	380.6K
Current Deferred Revenue	109.6K	916.9K	1.5M	5.5M	8.8M	9.3M
Other Current Assets	443.0K	154.9K	793.2K	687.0K	1.4M	1.5M
Net Tangible Assets	(1.7M)	(3.0M)	19.7M	(19.5M)	(17.6M)	(16.7M)
Net Invested Capital	(173.5K)	(1.5M)	22.8M	(8.6M)	21.8M	22.8M
Short Long Term Debt	814.7K	779.1K	63.4K	2.8M	327.6K	311.2K
Net Working Capital	(1.2M)	(1.4M)	22.1M	(20.1M)	7.8M	8.2M
Capital Stock	534.0K	3.9M	4.4M	4.9M	383.7K	364.5K
Intangible Assets	675.5K	715.8K	3.0M	12.7M	14.8M	15.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:

How To Invest In LifeMD

Details

Is LifeMD Stock a good investment?

Details

What is LifeMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for LifeMD Stock analysis

When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals

Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.70)

Revenue Per Share

4.499

Quarterly Revenue Growth

0.595

Return On Assets

(0.22)

Return On Equity

(7.82)

The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LifeMD Book Value per Share vs Enterprise Value Analysis

Book Value Per Share vs Enterprise Value

Book Value per Share vs Enterprise Value Correlation Analysis

Correlation Coefficient

Book Value Per Share

Enterprise Value

LifeMD fundamental ratios Correlations

LifeMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LifeMD fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for LifeMD Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Total Current Assets	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Retained Earnings	- 1.0	Total Current Liabilities
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Total Liab	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Other Current Liab
Non Current Assets Total	- 0.96	Retained Earnings